[1]
B. Jezeršek Novaković, V. Kotnik, T. Južnič Šetina, M. Vovk, and S. Novaković, “Testing of mechanisms of action of rituximab and clinical results in high-risk patients with aggressive CD20+ lymphoma”, Radiol Oncol, vol. 41, no. 1, Mar. 2007.